Display options
Share it on

J Evid Based Complementary Altern Med. 2014 Jul;19(3):181-188. doi: 10.1177/2156587214528513.

Expectancy, Self-Efficacy, and Placebo Effect of a Sham Supplement for Weight Loss in Obese Adults.

Journal of evidence-based complementary & alternative medicine

Kimberly M Tippens, Jonathan Q Purnell, William L Gregory, Erin Connelly, Douglas Hanes, Barry Oken, Carlo Calabrese

Affiliations

  1. 1 Helfgott Research Institute, National College of Natural Medicine, Portland, OR, USA.
  2. 2 Oregon Health & Science University, Portland, OR, USA.

PMID: 24695007 PMCID: PMC4182347 DOI: 10.1177/2156587214528513

Abstract

This study examined the role of expectancy in the placebo effect of a sham dietary supplement for weight loss in 114 obese adults with metabolic syndrome. All participants received lifestyle education and were randomized to 1 of 3 conditions: (1) a daily placebo capsule and told that they were taking an active weight loss supplement, (2) daily placebo and told they had a 50% random chance of receiving either the active or placebo, or (3) no capsules. At 12 weeks, weight loss and metabolic outcomes were similar among the 3 groups. Participants in both groups that took capsules showed decreased weight loss self-efficacy and increased expectations of benefit from dietary supplements. Participants not taking capsules showed the opposite. Adverse events were more frequently reported in groups taking capsules than those who were not. These findings suggest that supplements without weight loss effects may have nocebo effects through diminished self-efficacy.

Keywords: expectancy; metabolic syndrome; obesity; placebo; weight loss

References

  1. N Engl J Med. 2001 Oct 25;345(17):1276-7; author reply 1278-9 - PubMed
  2. Obes Res. 2001 Sep;9(9):552-63 - PubMed
  3. Altern Ther Health Med. 1996 Nov;2(6):39-54 - PubMed
  4. Pain. 2001 Mar;91(1-2):147-54 - PubMed
  5. CMAJ. 2001 Jul 24;165(2):174-9 - PubMed
  6. Science. 2002 Mar 1;295(5560):1737-40 - PubMed
  7. Psychosom Med. 1999 Mar-Apr;61(2):250-5 - PubMed
  8. J Orofac Pain. 2009 Spring;23(2):93-107 - PubMed
  9. N Engl J Med. 2002 Feb 7;346(6):393-403 - PubMed
  10. Am J Psychiatry. 2002 May;159(5):728-37 - PubMed
  11. Adv Mind Body Med. 2000 Winter;16(1):13-6 - PubMed
  12. Health Psychol. 1999 May;18(3):288-94 - PubMed
  13. Br Med J (Clin Res Ed). 1981 May 16;282(6276):1576-8 - PubMed
  14. J Neurosci. 2005 Nov 9;25(45):10390-402 - PubMed
  15. Health Psychol. 2000 Sep;19(5):487-95 - PubMed
  16. J Am Vet Med Assoc. 1999 Oct 1;215(7):992-9 - PubMed
  17. J Am Med Assoc. 1955 Dec 24;159(17):1602-6 - PubMed
  18. J Consult Clin Psychol. 1991 Oct;59(5):739-44 - PubMed
  19. N Engl J Med. 2001 May 24;344(21):1594-602 - PubMed
  20. Psychol Sci. 2011 Aug;22(8):1081-6 - PubMed
  21. J Intern Med. 2004 Aug;256(2):91-100 - PubMed
  22. Lancet. 2010 Feb 20;375(9715):686-95 - PubMed
  23. J Neurosci. 2005 Aug 24;25(34):7754-62 - PubMed
  24. Eval Health Prof. 2002 Dec;25(4):436-64 - PubMed
  25. Brain. 2008 Nov;131(Pt 11):2812-23 - PubMed
  26. Obesity (Silver Spring). 2008 Apr;16(4):790-6 - PubMed
  27. Science. 2001 Aug 10;293(5532):1164-6 - PubMed
  28. Adv Mind Body Med. 2000 Summer;16(3):216-32 - PubMed
  29. JAMA. 2001 May 16;285(19):2486-97 - PubMed
  30. N Engl J Med. 2009 Feb 26;360(9):859-73 - PubMed
  31. Neuropsychopharmacology. 2011 Jan;36(1):339-54 - PubMed
  32. Health Technol Assess. 1999;3(3):1-96 - PubMed
  33. Am Heart J. 1996 Dec;132(6):1207-21 - PubMed
  34. Med Klin (Munich). 2000 May;95(1 Spec No):23-30 - PubMed

Publication Types

Grant support